Uncategorized

Alongside the acquisitions, Edwards reported a slowdown in its core TAVR business in the second quarter that sent its shares tumbling.

Deployments of the new electronic health record have largely been on hold, except for the recent launch at a medical center in Illinois. Agency and Oracle officials said the rollout went well.

Rotech will help Owens & Minor get closer to its 2028 sales goal with home medical equipment, including sleep and oxygen devices, hospital beds and wheelchairs.

Philip Ebeling told Inspire he will resign to become president and CEO of “a private medical device company operating in the cardiology space.”

Tenet has an emerging “beat and raise” track record on Wall Street, analysts said, after the health system raised its full-year guidance for the second time this year.

While Humira sales were impacted by cheaper biosimilars, AbbVie reported in its second-quarter earnings results Thursday that revenues jumped nearly 45% for Skyrizi and almost 56% for Rinvoq year over year, respectively.

The three companies raised their respective full-year earnings forecasts on Thursday, buoyed by robust sales in the second quarter and their continued dominant market positions.

John Sackett will step into the role on Aug. 4.

Novartis continues its dealmaking spree with a bet on Dren Bio’s Targeted Myeloid Engager and Phagocytosis platform to develop bispecific antibodies in oncology.

The regulator on Wednesday provided recommendations to drugmakers for assessing the use of electronic health records and medical claims data to support their applications.